Prognosis of Gastric Carcinoid Tumours
The DOI matches its Crossref record.
Abstract
With the aim of evaluating the prognosis of carcinoid tumours of the stomach, the tumours were classified into subtypes on the basis of the type of gastritis, and a comparison made of the type of treatment, metastasizing rate, and the survival rates of the various groups of patients involved. Of the patients with atrophic autoimmune gastritis (type A gastritis) (n = 88) who had multiple carcinoid tumours in the corpus or fundus, usually not more than 1 cm in diameter, 98% were followed up clinically or by endoscopy and biopsy. In these patients, the metastasizing rate was 0%, and the age-corrected Kaplan-Meier survival rate revealed normal life expectancy. 25% of the patients with sporadic carcinoid tumours (n = 12)--most of whom had a Helicobacter pylori-related gastritis and usually solitary tumours located within the corpus of fundus, 25% of which exceeding 1 cm in diameter--underwent surgical treatment. In these patients the metastasizing rate was 16.7% and the age-corrected survival rate 79%. On the basis of our results, we conclude that, depending upon the subtype involved, the prognosis of gastric carcinoid tumours varies, such that regular endoscopy/biopsy follow-up suffices for patients with type A gastritis, while for patients with sporadic carcinoid tumours, surgical treatment is indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
KLÖPPEL, G., PERREN, A., & HEITZ, P. U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.002 · Cited by 794
Rindi, G., Azzoni, C., Rosa, S. L., Klersy, C., Paolotti, D., Rappel, S., Stolte, M., Capella, C., Bordi, C., & Solcia, E. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70174-5 · Cited by 354
Self-citationClassification and pathology of gastroenteropancreatic neuroendocrine neoplasms
Klöppel, G. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0013 · Cited by 336
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms
Delle Fave, G., Kwekkeboom, D. J., Van Cutsem, E., Rindi, G., Kos-Kudla, B., Knigge, U., Sasano, H., Tomassetti, P., Salazar, R., & Ruszniewski, P. (2012) · Neuroendocrinology · doi:10.1159/000335595 · Cited by 327
Borch, K., Ahrén, B., Ahlman, H., Falkmer, S., Granérus, G., & Grimelius, L. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000167862.52309.7d · Cited by 287
Metadata
- Authors
- Rappel, S., Altendorf-Hofmann, A., & Stolte, M.
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 1995
- Volume
- 56
- Issue
- 6
- Pages
- 455-462
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- OpenAlex
- W2049730221
- Cited by
- 142
- References
- 0
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognosis of Gastric Carcinoid Tumours. https://app.cochat.ai/papers/10.1159/000201276
- The paper
- Rappel, S., Altendorf-Hofmann, A., & Stolte, M. (1995). Prognosis of Gastric Carcinoid Tumours. Digestion. https://doi.org/10.1159/000201276
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.